» Articles » PMID: 8043932

Biochemical Aspects of the Blood Group Rh (rhesus) Antigens

Overview
Specialty Hematology
Date 1993 Jun 1
PMID 8043932
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Despite their importance in clinical haematology, the details of the structures and possible functions of the proteins associated with Rh antigen expression have only recently begun to emerge. The antigens are carried by a multimeric complex between a M(r) 30,000 polypeptide which is not glycosylated (the Rh30 polypeptide), and a heavily glycosylated glycoprotein (the Rh50 glycoprotein). The N-terminal amino acid sequences of the two types of proteins were determined and used to isolated cDNA clones. The Rh30 and Rh50 proteins are both very hydrophobic membrane proteins, each containing up to 12 membrane spans. The two proteins are homologous in sequence and clearly belong to the same family. They are erythroid-specific and not related to any other known family of proteins. The Rh30 polypeptides are the genetic determinants of Rh blood group antigen activity. One polypeptide (Rh30A) is probably associated with CcEe antigen activity, while another (Rh30B) is responsible for the D antigen. The proteins have structures typical of transporters but their functions are still unclear. A number of other red cell membrane proteins (LW, CD47, glycophorin B and Fy) show alterations in red cells lacking Rh antigens (Rhnull). These proteins may have a role in the biosynthesis or function of the Rh30 and Rh50 proteins.

Citing Articles

Analysis of macular thickness and peripapillary retinal nerve fiber layer thickness in various ABO and Rh blood groups.

Shanbezadeh E, Vasaghi-Gharamaleki B, Nabovati P, Koochakzadeh L, Khabazkhoob M BMC Ophthalmol. 2024; 24(1):307.

PMID: 39048995 PMC: 11267854. DOI: 10.1186/s12886-024-03577-5.


Molecular dynamics of the human RhD and RhAG blood group proteins.

Floch A, Galochkina T, Pirenne F, Tournamille C, de Brevern A Front Chem. 2024; 12:1360392.

PMID: 38566898 PMC: 10985258. DOI: 10.3389/fchem.2024.1360392.


The Clinical Utility of ABO and RHD Systems as Potential Indicators of Health Status, a Preliminary Study in Greek Population.

Lymperaki E, Stalika E, Tzavelas G, Tormpantoni E, Samara D, Vagdatli E Clin Pract. 2022; 12(3):406-418.

PMID: 35735664 PMC: 9221977. DOI: 10.3390/clinpract12030045.


Evaluation of maternal rhesus blood type as a risk factor in adverse pregnancy outcomes in Korea: a nationwide health insurance database study.

Jin Y, Dong M, Yang S, Lee K, Han S, Seo S Obstet Gynecol Sci. 2020; 63(4):448-454.

PMID: 32689772 PMC: 7393763. DOI: 10.5468/ogs.20004.


First Report of Known Rare Rhnull Phenotype Individuals in Iran.

Shahverdi E, Moghaddam M, Abolghasemi H Int J Hematol Oncol Stem Cell Res. 2019; 12(3):181-184.

PMID: 30595819 PMC: 6305262.